Direct Allergy, LLC
ERIE, PA · Founded 2012 · CIK 0001602421 · Medtech · Private
Allergen immunotherapy platform for treating allergies at the source
directallergy.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $735K
- 6 Form D · Apr 2020
- 78 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20132014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $200,000 | |
| Private capital raised | Form D · SEC | $200,000 | |
| Private capital raised | Form D · SEC | $85,000 | |
| Private capital raised | Form D · SEC | $150,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 979 | Nexstim Plc | — | $3.7M |
| 980 | SONAVI LABS, INC. | — | $770K |
| 981 | Nanosphere Health Sciences Inc. | — | $24M |
| 982 | Direct Allergy, LLC | — | $735K |
| 983 | ICHOR VASCULAR INC. | — | $3.1M |
| 984 | SPEECHVIVE, INC. | — | $280K |
| 985 | VIVAQUANT, LLC | — | $175K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jay GruhlkeyDirector · Executive Officer
- JAY GRUHLKEYExecutive Officer
- Kenneth HogueExecutive Officer
- MARILYN LANDISExecutive Officer
- WILLIAM PAGONISExecutive Officer
- Robert SchultzDirector · Executive Officer
- ROBERT SCHULTZExecutive Officer
- Joseph ZajacDirector · Executive Officer
- JOSEPH ZAJACExecutive Officer
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.